Intra-articular injection
Taiwan·Risk Class 3·MAXIGEN BIOTECH INC.·Registered Oct 10, 2019 – Aug 22, 2026Active- Analysis ID
- 07a1bc935638d8a6334e1a7a7ae5fe43
- Customs Code
- DHY00500217300
- Manufacturer
- MAXIGEN BIOTECH INC.
- Manufacturer Country
- Taiwan, Province of China
- Authorized Representative
- MAXIGEN BIOTECH INC.
- Intended Use
- As a treatment for patients with degenerative knee arthritis pain, it is limited to conservative non-pharmacological treatments and when general analgesics (eg, Acetaminophen) do not respond.
- Product Type (Level 1)
- N Orthopedics
- Import Information
- Domestic
- Registration Date
- Oct 10, 2019
- Expiry Date
- Aug 22, 2026
Top companies providing products similar to "Intra-articular injection"
Recently registered similar products
Access comprehensive regulatory information for Intra-articular injection in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 3 medical device is registered under number 07a1bc935638d8a6334e1a7a7ae5fe43 and manufactured by MAXIGEN BIOTECH INC.. The authorized representative in Taiwan is MAXIGEN BIOTECH INC..
This page provides complete technical specifications, regulatory compliance details, 5 companies making similar products including MAXIGEN BIOTECH INC., Yongxin Pharmaceutical Industry Co., Ltd. Taichung Lion Factory, and 5 recent registrations in the same category. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.